- Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease
-
Park J, Cheon JH
- KMID: 2427452
- Gut Liver.
- 2018 Nov;12(6):623-632.
- doi: 10.5009/gnl17462
Intestinal Behçet's disease is a rare, immune-mediated chronic intestinal inflammatory disease; therefore, clinical trials to optimize the management and treatment of patients are scarce. Moreover, intestinal Behçet's disease is difficult... -
- CITED
-
- Close
- SHARE
-
- Close
- Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis
-
Kang YM, Park YE, Park W, Choe JY, Cho CS, Shim SC, Bae SC, Suh CH, Cha HS, Koh EM, Song YW, Yoo B, Lee SS, Park MC, Lee SH, Arendt C, Koetse W, Lee SK
- KMID: 2426407
- Korean J Intern Med.
- 2018 Nov;33(6):1224-1233.
- doi: 10.3904/kjim.2016.213
BACKGROUND/AIMS: The objective of this study was to determine the efficacy and safety of add-on therapy with certolizumab pegol (CZP) in active rheumatoid arthritis (RA) patients of a single ethnicity. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
